Moxetumomab Pasudotox-tdfk and Olopatadine nasal
Determining the interaction of Moxetumomab Pasudotox-tdfk and Olopatadine nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: olopatadine nasal
Brand name: Patanase
Synonyms: Olopatadine (nasal), Olopatadine (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Olopatadine Nasal Spray
- Moxetumomab Pasudotox-tdfk-Olsalazine
- Moxetumomab Pasudotox-tdfk-Olsalazine Sodium
- Moxetumomab Pasudotox-tdfk-Olumiant
- Moxetumomab Pasudotox-tdfk-Olux
- Moxetumomab Pasudotox-tdfk-Olux-E
- Olopatadine nasal-Moxetumomab pasudotox-tdfk Intravenous
- Olopatadine nasal-Moxifloxacin
- Olopatadine nasal-Moxifloxacin (Systemic)
- Olopatadine nasal-Moxifloxacin Hydrochloride
- Olopatadine nasal-Moxifloxacin Injection
- Olopatadine nasal-Moxifloxacin Intravenous